Analysts/Institutional Investor Meet/Con. Call Updates

November 06, 2026 The Listing Department, The Corporate Relations Department, National Stock Exchange of India Limited BSE Limited NSE Symbol: VIJAYA BSE Scrip Code: 543350 Dear Sir/Madam, Subject: Transcript of the Earnings conference call organized on November 04, 2026 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and in furtherance to our letter dated October 28, 2026, we are enclosing herewith the Transcript of the Earnings Conference Call organized on November 04, 2026 post declaration of the Un-audited Financial Results of the Company for the quarter and half year ended September 30, 2026. Kindly take the same on record. Thanking You. Yours faithfully, for and on behalf of Vijaya Diagnostic Centre Limited Rahul Jain Company Secretary & Compliance Officer M.No. A62949 Encl.: As above “Vijaya Diagnostic Centre Limited Q2 FY '27 Earnings Conference Call” November 04, 2026 MANAGEMENT: MR. SUNIL CHANDRA KONDAPALLY – EXECUTIVE DIRECTOR, VIJAYA DIAGNOSTIC CENTRE LIMITED MR. NARASIMHA RAJU – CHIEF FINANCIAL OFFICER, VIJAYA DIAGNOSTIC CENTRE LIMITED MR. DHIREN GALA – HEAD, INVESTOR RELATIONS AND CORPORATE DEVELOPMENT, VIJAYA DIAGNOSTIC CENTRE LIMITED MODERATOR: MR. ABIN BENNY – JM FINANCIALS LIMITED Page 1 of 21 Vijaya Diagnostic Centre Limited November 04, 2026 Moderator: Ladies and gentlemen, good day, and welcome to Vijaya Diagnostic Q2 FY '27 Earnings Conference Call, hosted by JM Financial Institutional Securities Limited. As a reminder, all participant lines will be in the listen-only mode, and there will be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during the conference call, please signal an operator by pressing “*” then “0” on your touchtone phone. Please note that this conference is being recorded. I now hand the conference over to Mr. Abin Benny from JM Financial. Thank you, and over to you, sir. Abin Benny: Thank you, and good morning, everyone. I am Abin Benny. And on behalf of JM Financial, I would like to extend a warm welcome to all of you on the 2nd Quarter FY '27 Earnings Call of Vijaya Diagnostic Centre Limited. At the outset, I would like to thank the Management of Vijaya Diagnostics for giving us the opportunity to host the call. We look forward to having an engaging and insightful discussion on the company's quarterly performance and the outlook. From the company, we have with us today Mr. Sunil Chandra, Executive Director, Mr. Narasimha Raju, Chief Financial Officer, and Mr. Dhiren Gala, Head Investor Relations and Corporate Development. With that, I would now like to hand over the call to the Management for their opening remarks. Over to you, Sunil sir. Sunil Chandra Kondapally: Thank you, Abin, for JM Financial for hosting the call. Good morning, everyone, and thank you for joining us on today's call. So, as we approach the festive occasion of Diwali, I wish you all and your families a very Happy Diwali. Diwali is a time of togetherness, joy, and celebration when we take a moment from our busy schedules to spend time with our families and our loved ones. It is also a reminder that good health is the foundation of every celebration. And at Vijaya, we have always believed that timely diagnosis and preventive healthcare play an important role in helping families lead healthier and happier lives. This continues to be at the heart of everything we do as we expand our presence and we bring high-quality diagnostic services closer to our customers. Moving on to the business: We have continued to maintain strong momentum in our execution, while staying true to our core principles. We are very happy with the positive response to our brand across the newer Page 2 of 21 Vijaya Diagnostic Centre Limited November 04, 2026 geographies, which is clearly reflected in the performance delivered over the last couple of quarters. Coming to the recent quarter: Q2 FY '27, I am pleased to share that we have sustained our strong growth momentum with healthy contributions from across geographies. During the quarter, we delivered strong revenue growth of 26.7% year-on-year, supported by a healthy volume growth of 16.5%. And the balance was driven by favorable change in the mix and revision in CGHS tariffs. Our existing centers have also grown at a strong growth rate of 20%. The centers that we have opened in the last two years contributed to the balance growth, reflecting the strength of our established network as well as the healthy ramp-up of the newer facilities. So, I would like to also thank our entire team for their continued dedication and efforts in delivering this performance. Our core markets continue to demonstrate strong growth momentum, supported by healthy underlying demand for quality services and continued market share gains. We have also witnessed a meaningful turnaround in Pune with our network consistently delivering healthy double-digit growth over the past three to four quarters. We are encouraged by the positive response to our advanced technologies and quality of services, and that has reinforced our confidence in the potential of this region in the long term. And PH, which was an acquisition, continues to do well now. We continue to see encouraging momentum in West Bengal as our newest centers gradually mature and brand awareness also strengthens. We are also particularly pleased with the response in Tier-2 markets such as Krishnanagar and Diamond Harbour in Kolkata and Bengal. On the expansion front: We have commissioned two hub centers and seven spoke centers across our network so far during the year, that is in the first half. This includes our flagship hub at JP Nagar, Bengaluru, as highlighted during our previous call. Looking ahead, we expect to commission another three hubs in the second half of FY '27, followed by three additional hubs in Q1 FY '28, further strengthening our network and expanding our presence across key markets. Coming to our expansion plans in Hyderabad: We are witnessing particularly strong traction and faster ramp-up across our spoke centers in Western Hyderabad, mainly supported by the residential and commercial development, including it being the IT and financial district. To capitalize on this growing opportunity, we are planning to establish our third flagship diagnostic center in Hyderabad, equipped with state-of- the-art infrastructure and advanced diagnostic equipment. This will be the third after our Himayatnagar flagship and Panjagutta. Page 3 of 21 Vijaya Diagnostic Centre Limited November 04, 2026 Moving on to Pune: The sustained improvement in performance and encouraging customer response have strengthened our confidence to further invest in this market. As part of this, we are planning to relocate two of our existing hubs, Satara and Mayur Colony, to larger premises equipped with advanced better technology. This is also because of the current centers being quite congested. Therefore, the shift will help us to enhance the customer experience, improve outcomes, and also increase capacity to serve a higher number of customers. We believe these investments are well aligned with our long-term strategy of strengthening our presence in existing markets, upgrading our technological capabilities, and building a scalable infrastructure to support sustainable growth. During the quarter, we also entered into a business transfer agreement to acquire Arya Wellness Centre in Guwahati, Assam, and this marks our entry into the Northeast region and is an important step towards expanding our presence beyond our existing markets. We believe this acquisition provides us with a strong platform to establish our presence not only in Guwahati, but to also explore growth opportunities across the Northeast, leveraging our experience in integrated diagnostics and operational excellence. Our focus continues to remain on delivering high-quality services, enhancing customer experience, and expandin [Showing first 8,000 characters — download PDF for full document]